Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2020

01-11-2020 | Hepatitis B | Original Article

Analysis of pathological changes and related factors in liver tissue of HBeAg-negative patients with low HBsAg levels

Authors: Li Liu, Chunyun Liu, Junyi Li, Yingrong Du, Jie Chen, Hui Wang, Huimin Li, Lixian Chang

Published in: Clinical and Experimental Medicine | Issue 4/2020

Login to get access

Abstract

The relationship between pathological changes in liver tissue and the level of hepatitis B surface antigen (HBsAg) remains unclear. This study aimed to analyze the pathological changes in liver tissue and its related factors in patients with low-level HBsAg in order to provide a basis for judging the condition of these patients. A retrospective study was performed on 96 chronic hepatitis B patients with HBsAg levels < 1400 IU/ml and > 0.05 IU/ml. The histopathological examination of these patients was conducted. Univariate and multivariate analyses were used to determine risk factors for pathological changes. Among the 96 patients, 57.3% (55) had inflammatory events ≥ G2 and 33.4% (33) had fibrosis ≥ S2. HBV infection duration (p = 0.001) and splenic vein diameter (p = 0.001) were independent risk factors of liver inflammation (≥ G2) in patients with low-level HBsAg, while AST (p = 0.006) and PLT (p = 0.005) were independent risk factors of liver fibrosis (≥ S2). Moreover, HBV infection duration (p < 0.001) and spleen vein (p = 0.001) were independent factors of potential antiviral treatment. Liver inflammation and fibrosis are still common in patients with low-level HBsAg; thus, the monitoring and appropriate antiviral treatment cannot be ignored.
Literature
2.
go back to reference Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J. 2009;122:1–2. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J. 2009;122:1–2.
9.
go back to reference Thompson AJ, Nguyen T, Lser D. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intra-hepatic hepatitis B virus markers. Hepatology. 2010;51:1933–44.CrossRef Thompson AJ, Nguyen T, Lser D. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intra-hepatic hepatitis B virus markers. Hepatology. 2010;51:1933–44.CrossRef
17.
go back to reference Tran TT. Immune tolerant hepatitis B: a clinical dilemma. Gastroenterol Hepatol. 2011;7(8):511–6. Tran TT. Immune tolerant hepatitis B: a clinical dilemma. Gastroenterol Hepatol. 2011;7(8):511–6.
20.
go back to reference Lu W, Zhang ZQ, Shen F. Serum HBsAg levels and HBV DNA loads in prediction of hepatic histological activity grading and fibrosis staging in patients with chronic hepatitis B. J Pract Hepatol. 2016;19(1):20–5. Lu W, Zhang ZQ, Shen F. Serum HBsAg levels and HBV DNA loads in prediction of hepatic histological activity grading and fibrosis staging in patients with chronic hepatitis B. J Pract Hepatol. 2016;19(1):20–5.
21.
go back to reference Qiu HF, Li JH, Yang WJ. Analysis of related factors of liver pathology in patients with chronic hepatitis B infection sustained normal alanine aminotransferase. Chin J Nosocomiol. 2015;25(17):3893–5. Qiu HF, Li JH, Yang WJ. Analysis of related factors of liver pathology in patients with chronic hepatitis B infection sustained normal alanine aminotransferase. Chin J Nosocomiol. 2015;25(17):3893–5.
23.
go back to reference Nguyen LH, Chao D, Lim JK, Ayoub W, Nguyen MH. Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic review. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12(8):1262–6. https://doi.org/10.1016/j.cgh.2013.11.038.CrossRef Nguyen LH, Chao D, Lim JK, Ayoub W, Nguyen MH. Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic review. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12(8):1262–6. https://​doi.​org/​10.​1016/​j.​cgh.​2013.​11.​038.CrossRef
25.
go back to reference Shin KH, Lee HJ, Chang CL, Kim HH. Performance of the cobas Hepatitis B virus (HBV) test using the cobas 4800 system and comparison of HBV DNA quantification ability between the COBAS AmpliPrep/COBAS TaqMan HBV test version 2.0 and cobas HBV test. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2018;101:47–51. https://doi.org/10.1016/j.jcv.2018.01.012.CrossRef Shin KH, Lee HJ, Chang CL, Kim HH. Performance of the cobas Hepatitis B virus (HBV) test using the cobas 4800 system and comparison of HBV DNA quantification ability between the COBAS AmpliPrep/COBAS TaqMan HBV test version 2.0 and cobas HBV test. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2018;101:47–51. https://​doi.​org/​10.​1016/​j.​jcv.​2018.​01.​012.CrossRef
34.
go back to reference Ding HB, Li YX, Lai JQ. Analysis of the correlation between pathological changes and inner diameter of portal vein in liver tissue of patients with chronic hepatitis B. J Prac Hepatol. 2010;13(5):369–70. Ding HB, Li YX, Lai JQ. Analysis of the correlation between pathological changes and inner diameter of portal vein in liver tissue of patients with chronic hepatitis B. J Prac Hepatol. 2010;13(5):369–70.
35.
go back to reference Wang Q, Li X, Hu K, Zhao K, Yang P, Liu B. Logistic regression model of noninvasive prediction for portal hypertensive gastropathy in patients with hepatitis B associated cirrhosis. Zhonghua yi xue za zhi. 2015;95(18):1411–4.PubMed Wang Q, Li X, Hu K, Zhao K, Yang P, Liu B. Logistic regression model of noninvasive prediction for portal hypertensive gastropathy in patients with hepatitis B associated cirrhosis. Zhonghua yi xue za zhi. 2015;95(18):1411–4.PubMed
36.
go back to reference Akande KO, Akere A, Otegbayo JA, Ola SO, Ousunmade D. Accuracy of non-endoscopic predictors of oesophageal varices in liver cirrhosis using platelet count, splenic size and portal vein diameter. Afr J Med Med Sci. 2016;45(3):243–51.PubMed Akande KO, Akere A, Otegbayo JA, Ola SO, Ousunmade D. Accuracy of non-endoscopic predictors of oesophageal varices in liver cirrhosis using platelet count, splenic size and portal vein diameter. Afr J Med Med Sci. 2016;45(3):243–51.PubMed
38.
go back to reference Huo XP, Xie QX, Jiang XP. Pathological changes of liver tissues in 486 patients with chronic hepatitis B. J Prac Hepatol. 2015;18(4):360–3. Huo XP, Xie QX, Jiang XP. Pathological changes of liver tissues in 486 patients with chronic hepatitis B. J Prac Hepatol. 2015;18(4):360–3.
Metadata
Title
Analysis of pathological changes and related factors in liver tissue of HBeAg-negative patients with low HBsAg levels
Authors
Li Liu
Chunyun Liu
Junyi Li
Yingrong Du
Jie Chen
Hui Wang
Huimin Li
Lixian Chang
Publication date
01-11-2020
Publisher
Springer International Publishing
Keyword
Hepatitis B
Published in
Clinical and Experimental Medicine / Issue 4/2020
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-020-00645-0

Other articles of this Issue 4/2020

Clinical and Experimental Medicine 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.